跳至主要内容
临床试验/CTRI/2013/11/004167
CTRI/2013/11/004167招募中1 期

Pharmaceutical standardization of kamsaharitaki avaleha & its granules and its effect on Tamaka Shwasa (Bronchial Asthma)

Institute for Post Graduate Teaching and Research in Ayurveda0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients presenting with classical signs and symptoms of Tamaka Shwasa,
  • Both the sexes having age between 16 years to 60 years
  • Mild persistent cases of Bronchial Asthma with daytime symptoms 3-6/week and nocturnal symptoms with 3-4/month.
  • Moderate persistence cases with daytime symptoms daily and nocturnal symptoms with one or more than one week but not more than 2 weeks.

排除标准

  • Known patients of diabetes,
  • Dyspnoea resulting from cardiac origin, anaemia,
  • Age above 60 years and below 16 years,
  • Patients suffering from tuberculosis, malignancy and other chronic debilitating diseases, HIV positive cases,
  • Pregnant and lactating mothers and
  • Patients who depend on regular use of inhalers,
  • Patients suffering with other types of Shwasa, i.e. Maha, Urdha, Chhinna Shwasa will be excluded from the study.

研究者

发起方
Institute for Post Graduate Teaching and Research in Ayurveda

相似试验